If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Domenico Mallardo is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 11 Similar Profiles
Melanoma Medicine & Life Sciences
Survival Medicine & Life Sciences
Drug Resistance Medicine & Life Sciences
Matrix Metalloproteinase 9 Medicine & Life Sciences
Mutation Medicine & Life Sciences
Natural Killer Cells Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Mitogen-Activated Protein Kinase Kinases Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2015 2019

  • 130 Citations
  • 7 h-Index
  • 15 Article

Accumulation of Circulating CCR7+ Natural Killer Cells Marks Melanoma Evolution and Reveals a CCL19-Dependent Metastatic Pathway

Cristiani, C. M., Turdo, A., Ventura, V., Apuzzo, T., Capone, M., Madonna, G., Mallardo, D., Garofalo, C., Giovannone, E. D., Grimaldi, A. M., Tallerico, R., Marcenaro, E., Pesce, S., Zotto, G. D., Agosti, V., Costanzo, F. S., Gulletta, E., Rizzo, A., Moretta, A., Karre, K. & 3 others, Ascierto, P. A., Todaro, M. & Carbone, E., May 2019, In : Cancer immunology research. 7, 5, p. 841-852 12 p.

Research output: Contribution to journalArticle

Natural Killer Cells
Neoplastic Stem Cells
T-Lymphocyte Subsets

Early fatigue in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: An insight from clinical practice

Cortellini, A., Vitale, M. G., De Galitiis, F., Di Pietro, F. R., Berardi, R., Torniai, M., De Tursi, M., Grassadonia, A., Di Marino, P., Santini, D., Zeppola, T., Anesi, C., Gelibter, A., Occhipinti, M. A., Botticelli, A., Marchetti, P., Rastelli, F., Pergolesi, F., Tudini, M., Silva, R. R. & 5 others, Mallardo, D., Vanella, V., Ficorella, C., Porzio, G. & Ascierto, P. A., Nov 15 2019, In : Journal of Translational Medicine. 17, 1, 376.

Research output: Contribution to journalArticle

Corrosion inhibitors
Fatigue of materials
Renal Cell Carcinoma

ErbB3 Phosphorylation as Central Event in Adaptive Resistance to Targeted Therapy in Metastatic Melanoma: Early Detection in CTCs during Therapy and Insights into Regulation by Autocrine Neuregulin

Ruggiero, C. F., Malpicci, D., Fattore, L., Madonna, G., Vanella, V., Mallardo, D., Liguoro, D., Salvati, V., Capone, M., Bedogni, B., Ascierto, P. A., Mancini, R. & Ciliberto, G., Sep 25 2019, In : Cancers. 11, 10

Research output: Contribution to journalArticle

Circulating Neoplastic Cells
Cell- and Tissue-Based Therapy
5 Citations (Scopus)

Proteomic test for anti-PD-1 checkpoint blockade treatment of metastatic melanoma with and without BRAF mutations

Ascierto, P. A., Capone, M., Grimaldi, A. M., Mallardo, D., Simeone, E., Madonna, G., Roder, H., Meyer, K., Asmellash, S., Oliveira, C., Roder, J. & Grigorieva, J., Mar 29 2019, In : Journal for ImmunoTherapy of Cancer. 7, 1, 91.

Research output: Contribution to journalArticle

Disease-Free Survival

Reprogramming miRNAs global expression orchestrates development of drug resistance in BRAF mutated melanoma

Fattore, L., Ruggiero, C. F., Pisanu, M. E., Liguoro, D., Cerri, A., Costantini, S., Capone, F., Acunzo, M., Romano, G., Nigita, G., Mallardo, D., Ragone, C., Carriero, M. V., Budillon, A., Botti, G., Ascierto, P. A., Mancini, R. & Ciliberto, G., Jul 2019, In : Cell Death and Differentiation. 26, 7, p. 1267-1282 16 p.

Research output: Contribution to journalArticle

Drug Resistance
Mitogen-Activated Protein Kinase Kinases